CHA
TMO icon

Cooper/Haims Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Cooper/Haims Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-394
Closed -$218K – 88
2024
Q2 		$218K Buy
394
+47
+14% +$26.9K 0.12% 76
2024
Q1 		$202K Buy
+347
New +$195K 0.12% 77

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cooper/Haims Advisors's TMO Position: Q3 2024 in Review

Cooper/Haims Advisors sold out of Thermo Fisher Scientific (TMO) in Q3 2024, closing a stake of 394 shares — an estimated $218K sold.

Cooper/Haims Advisors first reported a position in TMO in Q1 2024 and held it in 2 quarters. The position peaked at $218K in Q2 2024. 2,568 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

  • Cooper/Haims Advisors reported no remaining Thermo Fisher Scientific position as of Q3 2024 after selling out during the quarter.
  • Cooper/Haims Advisors sold 394 Thermo Fisher Scientific shares in Q3 2024, an estimated $218K.
  • Cooper/Haims Advisors first reported a position in Thermo Fisher Scientific in Q1 2024 and held it in 2 quarters.
  • Cooper/Haims Advisors's Thermo Fisher Scientific position peaked at $218K in Q2 2024.
  • 2,568 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Cooper/Haims Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.